(Q41462618)

1 October 2017

title

Protection against plague afforded by immunisation with DNA vaccines optimised for expression of the Yersinia pestis V antigen (English)

1 reference

1 October 2017

0 references

4

Richard W Titball

1 reference

1 October 2017

Helen S Garmory

1

1 reference

1 October 2017

Donna Freeman

series ordinal

2

1 reference

1 October 2017

Katherine A Brown

series ordinal

3

1 reference

1 October 2017

language of work or name

English

0 references

publication date

1 February 2004

1 reference

1 October 2017

number of pages

11

1 reference

inferred from page(s)

published in

Vaccine

1 reference

1 October 2017

volume

22

1 reference

1 October 2017

issue

8

1 reference

1 October 2017

page(s)

947-957

1 reference

Yersinia pestis--etiologic agent of plague

1 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Plague Immunization. I. Past and Present Trends

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Plague Immunization. V. Indirect Evidence for the Efficacy of Plague Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

A sub-unit vaccine elicits IgG in serum, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Plague Immunization, II. Relation of Adverse Clinical Reactions to Multiple Immunizations with Killed Vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Protection against experimental bubonic and pneumonic plague by a recombinant capsular F1-V antigen fusion protein vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

A single dose sub-unit vaccine protects against pneumonic plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Plasmid DNA expression systems for the purpose of immunization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

7 January 2021

DNA vaccines: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Genetic immunization is a simple method for eliciting an immune response

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Gene gun mediated vaccination is superior to manual delivery for immunisation with DNA vaccines expressing protective antigens from Yersinia pestis or Venezuelan Equine Encephalitis virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Effect of different promoters on immune responses elicited by HIV-1 gag/env multigenic DNA vaccine in Macaca mulatta and Macaca nemestrina

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Efficient vaccination by intradermal or intramuscular inoculation of plasmid DNA expressing hepatitis B surface antigen under desmin promoter/enhancer control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

The effect of eukaryotic expression vectors and adjuvants on DNA vaccines in chickens using an avian influenza model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Intradermal immunization with a bovine herpesvirus-1 DNA vaccine induces protective immunity in cattle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Immune responses to nucleic acid vaccines to rabies virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Optimization of transcriptional regulatory elements for constructing plasmid vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Multiple effects of codon usage optimization on expression and immunogenicity of DNA candidate vaccines encoding the human immunodeficiency virus type 1 Gag protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Codon optimization of gene fragments encoding Plasmodium falciparum merzoite proteins enhances DNA vaccine protein expression and immunogenicity in mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Influence of codon usage on the immunogenicity of a DNA vaccine against tetanus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Gene gun DNA vaccination with Rev-independent synthetic HIV-1 gp160 envelope gene using mammalian codons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

pEF-BOS, a powerful mammalian expression vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

The SV40 72 base repair repeat has a striking effect on gene expression both in SV40 and other chimeric recombinants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

The human ubiquitin C promoter directs high ubiquitous expression of transgenes in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Recognition of AUG and alternative initiator codons is augmented by G in position +4 but is not generally affected by the nucleotides in positions +5 and +6.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Codon usage tabulated from the GenBank genetic sequence data

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Oral immunisation with live aroA attenuated Salmonella enterica serovar Typhimurium expressing the Yersinia pestis V antigen protects mice against plague

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

A comparison of Plague vaccine, USP and EV76 vaccine induced protection against Yersinia pestis in a murine model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Codon optimization of the gene encoding a domain from human type 1 neurofibromin protein results in a threefold improvement in expression level in Escherichia coli

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

DNA vaccines: protective immunizations by parenteral, mucosal, and gene-gun inoculations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Advantage of gene gun-mediated over intramuscular inoculation of plasmid DNA vaccine in reproducible induction of specific immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

Increased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

7 January 2021

inferred from DOI database lookup

Oral vaccination against tetanus: comparison of the immunogenicities of Salmonella strains expressing fragment C from the nirB and htrA promoters.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

7 January 2021

inferred from DOI database lookup

Active immunization with recombinant V antigen from Yersinia pestis protects mice against plague

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.09.020

7 January 2021

inferred from DOI database lookup

Identifiers

DOI

10.1016/J.VACCINE.2003.09.020

1 reference

release_glybfl7tizej5n4uhftj3vlseu

1 October 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/glybfl7tizej5n4uhftj3vlseu

24 November 2022

mapped directly with Wikidata item

1 reference